A Comparison of Surveillance Strategies for the Early Detection of Hepatocellular Carcinoma: A Case Control Study
Comparison of hepatitis B reactivation in patients with resolved hepatitis B infection receiving rituximab or non-rituximab based immunosuppressive therapy. Does the presence of hepatitis b surface antibody reduce risk of reactivation?
Increased Myostatin/Skeletal Mass Index Ratio is a Predictor of Worse Survival in Hepatitis B Virus-related Liver Cirrhosis
Comparative Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Tenofovir- or Entecavir-Based Regimens: A Meta-Analysis Using Individual Patient Data
Clinical outcomes of variceal and non-variceal upper gastrointestinal bleeding in patients with liver cirrhosis
Evaluation of Renal and Bone Safety at 4 Years in Post-Liver Transplant Patients With Chronic Kidney Disease Receiving Tenofovir Alafenamide for HBV Prophylaxis
Safety and Efficacy at 1 Year in Children and Adolescents With Chronic Hepatitis B Receiving Tenofovir Alafenamide
Sofosbuvir/ Velpatasvir/ Voxilaprevir for DAA-experienced HCV Patients: A Systematic Review and Meta-Analysis
Meld 3.: An Updated Model for Prediction of Mortality Amongst Patients with Cirrhosis Validated in a Large Tertiary Hospital in Singapore
Maximizing Iron Absorption in Inflammatory Bowel Disease: An Updated Systematic Review and Meta-Analysis of Intravenous Vs Oral Iron Therapy
Efficacy and Safety of Bulevirtide Monotherapy Given at 2 mg or 10 mg Dose Level Once Daily for Treatment of Chronic Hepatitis Delta: Week 48 Primary Endpoint Results From a Phase 3 Randomized, Multicenter, Parallel Design Study
